Risperidone-bound engineered human D2 receptor structure
Biochemical assay · Engineered human D2 long receptor with T4 lysozyme fusion and I122A/L375A/L379A thermostabilizing mutations. [1]
A 2.9 Å X-ray structure shows an inactive-state D2 receptor complex. The ligand tertiary amine contacts Asp114, while the benzisoxazole group occupies a deep hydrophobic pocket. The engineered construct and crystal environment limit direct extrapolation to native receptor dynamics.
| Endpoint | Reported result | Reference |
|---|---|---|
| Diffraction resolution of the risperidone-bound receptor complex | resolution 2.90 Å | [1] |
Literature-Reported Treatment Conditions
- Method
- Risperidone-bound receptor purified and crystallized in lipidic cubic phase; structural endpoint.
- Reported limits
- A single treatment concentration/duration is not applicable to this multistage structural preparation. No salt, analytical purity or supplier lot specified in the read methods.
Methods and source locations
Compound reported in the paper: Risperidone
Compound-level evidence for risperidone; no validation of A10797 or an Adooq lot.
Main text structural results; Figures 1–2 and captions; Extended Data Tables 1–2; Methods: Protein engineering, purification, crystallization and structure determination
Diffraction resolution of the risperidone-bound receptor complex: X-ray diffraction; data merged from 20 crystals. — Main text structural results; Figure 1; Extended Data Table 2